WO1992016556A1 - Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant - Google Patents

Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant Download PDF

Info

Publication number
WO1992016556A1
WO1992016556A1 PCT/EP1991/002047 EP9102047W WO9216556A1 WO 1992016556 A1 WO1992016556 A1 WO 1992016556A1 EP 9102047 W EP9102047 W EP 9102047W WO 9216556 A1 WO9216556 A1 WO 9216556A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
hiv
gplδo
vaccine
oligomer
Prior art date
Application number
PCT/EP1991/002047
Other languages
French (fr)
Inventor
Frans Van Wijnendale
Moncef Slaoui
Claudine Bruck
Myriam Francotte
Suzy Kummert
Original Assignee
Smithkline Beecham Biologicals (S.A.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9106048.3 priority Critical
Priority to GB919106048A priority patent/GB9106048D0/en
Application filed by Smithkline Beecham Biologicals (S.A.) filed Critical Smithkline Beecham Biologicals (S.A.)
Publication of WO1992016556A1 publication Critical patent/WO1992016556A1/en
Priority claimed from NO933342A external-priority patent/NO933342D0/en

Links